- Home
- /
- Treatment
- /
- Page 117
Treatments
The following database contains products that have been granted orphan status, or have been market approval in the EU or the USA.
You can filter the content by clicking on the titles: Product, Indication, Sponsor and Date. Clicking once, will filter the column alphabetically from A – Z and a second click on the same title will filter from Z – A.
Become a Partner.
Country | Product | Indication | Sponsor | Date |
---|---|---|---|---|
Albuterol | Prevention of paralysis due to spinal cord injury | MotoGen, Inc.;3 Pine View Road;Mount Kisco, New York, 10549 | March 12, 2002 | |
Aztreonam | Cystic fibrosis | Gilead Sciences (formerly Corus Pharma);199 East Blaine St;Seattle, Washington, 98102 | March 12, 2002 | |
I(131)-TM-601 (chlorotoxin) | Glioma | Morphotek, Inc.;210 Welsh Pool Road;Exon, Pennsylvania, 19341 | February 14, 2002 | |
Creatine | Amyotrophic lateral sclerosis | Avicena Group, Inc.;580 California St., Suite 1600;San Francisco, California, 94104 | February 12, 2002 | |
Recombinant immunotoxin combining the functional components of antibody against mesothelin and the enzymatic activity of a pseudomonas exotoxin | Ovarian epithelial cancer | National Institutes of Health;Cancer Therapy Evaluation Program, 6130 Executive Blvd, Suite 7111;Rockville, Maryland, 20852 | February 11, 2002 | |
Bioartificial liver system utilizing xenogenic hepatocytes in a hollow fiber bioreactor cartridge (BAL) | Patients with acute liver failure presenting with encephalopathy deteriorating beyond Parson's grade 2 | Excorp Medical, Inc.;Suite 235, 7200 Hudson Blvd.;Oakdale, Minnesota, 55128 | February 11, 2002 | |
Recombinant immunotoxin combining the functional components of antibody against mesothelin and the enzymatic activity of a pseudomonas exotoxin | Malignant pleural mesothelioma | National Institutes of Health;Cancer Therapy Evaluation Program, 6130 Executive Blvd, Suite 7111;Rockville, Maryland, 20852 | February 11, 2002 | |
Clofarabine | Acute lymphoblastic leukemia | Genzyme Corporation;4545 Horizon Hill Blvd.;San Antonio, Texas, 78229 | February 7, 2002 | |
Adenovirus-mediated Herpes simplex Virus-thymidine kinase gene | Glioma | Gliotherapy Limited | February 6, 2002 | |
Lipase, amylase, and protease | Pancreatic insufficiency | Altus Biologics Inc.;625 Putnam Avenue;Cambridge, Massachusetts, 02139 | January 23, 2002 | |
Carbamic acid, [[4-[[3-[[4-[1-(4-hydroxyphenyl)-1-methyl-ethyl]phenoxy]methyl]phenyl]methoxy]-phenyl]iminomethyl]-,ethyl ester | Cystic fibrosis | Boehringer Ingelheim Pharmaceuticals, Inc;900 Ridgebury Road, P.O. Box 368;Ridgefield, Connecticut, 06877 | January 15, 2002 | |
Deferiprone | Iron overload in patients with hematologic disorders requiring chronic transfusion therapy | ApoPharma, Inc. A Division of;Apotex Research Inc., Toronto, Canada M9L 1T9; | December 12, 2001 | |
Bryostatin-1 | Esophageal cancer | GPC Biotech, Inc.;610 Lincoln Street;Waltham, Massachusetts, 02451 | December 3, 2001 | |
Conjugate of human transferrin and a mutant diphtheria toxin (CRM 107) | Malignant tumors of the central nervous system | Xenova Biomedix Limited;957 Budkingham Avenue, Slough; | December 3, 2001 | |
Azacitidine | Myelodysplastic syndromes | Celgene Corporation;9900 W. 109th Street, Suite 300;Overland Park, Kansas, 66210 | December 3, 2001 | |
Hu1D10, humanized monoclonal antibody | For use in the treatment of 1D10+ B cell non-Hodgkin's lymphoma | PDL BioPharma, Inc.;34801 Campus Drive;Fremont, California, 94555 | November 28, 2001 | |
2-chloroethyl-3-sarcosinamide-1-nitrosourea | Glioma | Pangene Corporation;5500 Stewart Avenue;Fremont, California, 94538 | November 15, 2001 | |
Cintredekin besudotox | Glioma | Insys Development Company, Inc.;1333 South Sprectum Blvd, Suite 100;Chandler, Arizona, 85286 | November 2, 2001 | |
Digitoxin | Ovarian cancer | SimRx Advisors LLC;247 West 87th Street, Suite 7G;New York, New York, 10024 | November 2, 2001 | |
IL13-PE38QQR | Glioma | Insys Development Company, Inc.;1333 South Sprectum Blvd, Suite 100;Chandler, Arizona, 85286 | November 2, 2001 | |
Arsenic | Acute myelocytic leukemia | Teva Branded Pharmaceutical Products R&D;, Inc.;41 Moores Road, P. O. Box 4011;Frazer, Pennsylvania, 19355 | November 2, 2001 | |
T-cell depleted stem cell enriched cellular product from peripheal b lood stem cells | Chronic granulomatous disease | Nexell Therapeutics Inc.;9 Parker;Irvine, California, 92618 | November 1, 2001 | |
Acetylcysteine | For the intravenous treatment of moderate to severe acetaminophen overdose | Cumberland Pharmaceuticals, Inc.;209 10th Street South, Suite 332;Nashville, Tennessee, 37203 | October 19, 2001 | |
Nitisinone | Alkaptonuria | Swedish Orphan AB;Kungsgatan 37, 7th Floor, SE-111 56; | October 19, 2001 | |
Digitoxin | Soft tissue sarcomas | SimRx Advisors LLC;247 West 87th Street, Suite 7G;New York, New York, 10024 | October 18, 2001 |